The Centers for Medicare & Medicaid Services will cover DexCom Inc.'s (Nasdaq: DXCM) continuous glucose monitoring system Dexcom G5 Mobile. Shares of the medical device maker leaped $17.52 to close at $85.13.
Medicare to cover Dexcom G5 Mobile
January 13, 2017 at 17:49 PM EST